News Conference News ESC 2025 HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients Caitlin E. Cox September 01, 2025
News Conference News ACC 2025 Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT Caitlin E. Cox March 29, 2025
News Daily News IVC Filter Lawsuits Expose Holes in FDA Oversight and Public Communication L.A. McKeown December 03, 2024
News Conference News VIVA 2024 DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years L.A. McKeown November 11, 2024
News Daily News IVC Filter Use Declining, but Retrieval Rates Abysmally Low: SAFE-IVC Michael O'Riordan November 11, 2024
News Daily News Hormonal Birth Control, NSAID Use Together Linked to VTE Caitlin E. Cox September 11, 2023
News Conference News ESC 2023 ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients L.A. McKeown August 30, 2023
News Daily News OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer L.A. McKeown December 16, 2022
News Daily News Don’t Skimp on Anticoagulation in Isolated Distal DVT: RIDTS Todd Neale December 01, 2022
News Conference News TCT 2022 Dedicated Catheter for Acute PE Shows Promise in IDE Trial L.A. McKeown September 17, 2022
News Daily News Enoxaparin Tops Aspirin for Preventing VTE After Hip or Knee Arthroplasty Todd Neale August 25, 2022
News Daily News Two Large Studies Affirm Rare Thrombosis Risk With ChAdOx1 COVID-19 Vax Michael O'Riordan February 23, 2022
News Daily News DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis L.A. McKeown January 20, 2022
News Daily News Shorter Anticoagulation an Option for Young Patients With Provoked VTE Todd Neale January 11, 2022
News Daily News Select COVID-19 Patients May Benefit From Postdischarge Anticoagulation Todd Neale November 25, 2021
News Conference News AXIOMATIC-TKR: Milvexian Promising for VTE Prevention L.A. McKeown November 15, 2021
News Daily News Long-term Anticoagulation After Unprovoked VTE: New Insights Shelley Wood September 13, 2021